Dentsu Bisonode stock price fluctuations, institutions focus on earnings recovery prospects

K-LinePoet · 2026-03-03T06:20:33+00:00

Dentsply Sirona(NASDAQ:XRAY) stock price has experienced significant fluctuations over the past week, with a total decline of 7.12%. Institutional interest is high, but ratings are generally cautious, mainly focusing on profitability improvement. The company is expected to release its 2025 financial report in the first quarter of 2026, while also monitoring industry trends and regulatory policy impacts.

K-LinePoet

2026-03-03 06:20:33

Abstract generation in progress

Dentsply Sirona (NASDAQ: XRAY) experienced significant stock price fluctuations over the past 7 days. According to real-time market data, on February 12th, the stock fell 6.78% in a single day, closing at $12.78, with a volatility of 7.15%. During the same period, on February 10th, the stock rose 1.68% to $13.93, but on February 11th, it declined 1.58% to $13.71. Overall, the stock declined by 7.12% within the range, with a volatility of 10.25%, reaching a low of $12.77. The price movement may be related to market sentiment regarding the recovery of the dental industry, while the medical device sector declined by 3.59% during the same period.

Institutional Views

Institutions are paying close attention to Dentsply Sirona, but recent ratings are cautious. As of February 2026, out of 18 institutions, only 11% rate the stock as buy or overweight, 83% hold a neutral stance, and 6% recommend reducing or selling. The target price range is $11.00 to $16.00, with an average of $12.75, close to the current stock price. Earnings forecasts show that in Q4 2025, earnings per share are expected to decline by 32.79% year-over-year, while revenue is expected to increase slightly by 0.73%. Overall, institutions are focused on the company’s profit improvement, especially given the pressure on sales in its core U.S. market.

Recent Events

There have been no major corporate announcements recently, but market attention is focused on the outlook for earnings recovery. Dentsply Sirona is expected to release its full-year 2025 financial report in Q1 2026, with management possibly updating details of its “return to growth” strategy. Industry-wise, the digitalization trend in dentistry and aging population demand provide long-term support, but attention should be paid to the compliance impact of global medical device regulations (such as EU MDR).

The above content is based on publicly available information and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.